BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31552146)

  • 1. Brain Metastases in Patients with Gynecologic Cancers: A Single Institution Experience and Review of the Literature.
    Gilani MA; Williams NL; Giordano C; Rosenblum N; Shi W; Anne P; Schilder RJ
    Open J Obstet Gynecol; 2016 Aug; 6(9):544-552. PubMed ID: 31552146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in 20 Gynecologic Cancer Patient with Brain Metastasis: A Single Institution Retrospective Study.
    Kim SB; Hwang K; Joo JD; Han JH; Kim YB; Kim CY
    Brain Tumor Res Treat; 2017 Oct; 5(2):87-93. PubMed ID: 29188209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience.
    Falkson SR; Bhambhvani HP; Hayden Gephart M
    World Neurosurg; 2020 Aug; 140():e27-e32. PubMed ID: 32289508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Metastases From Gynecologic Malignancies: Prevalence and Management.
    Nasioudis D; Persaud A; Taunk NK; Latif NA
    Am J Clin Oncol; 2020 Jun; 43(6):418-421. PubMed ID: 32235163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of 23 gynecologic carcinoma patients with brain metastasis].
    Zhang JX; Wang SZ; Li B; Zhang ZY
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1843-6. PubMed ID: 27356795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the Literature.
    Gressel GM; Lundsberg LS; Altwerger G; Katchi T; Azodi M; Schwartz PE; Ratner ES; Damast S
    Int J Gynecol Cancer; 2015 Nov; 25(9):1711-6. PubMed ID: 26332394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis.
    da Costa AABA; Dos Santos ES; Cotrim DP; Pandolfi NC; Cesca MG; Mantoan H; Sanches SM; Ribeiro ARG; de Brot L; Bonvolim G; Sanematsu PI; de Souza RP; Maya JML; de Souza Castro F; da Nogueira Silveira Lima JP; Chen MJ; Guimarães APG; Baiocchi G
    BMC Cancer; 2019 Dec; 19(1):1194. PubMed ID: 31805898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
    Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
    Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of CNS metastases from primary gynecologic cancers.
    Zhang Y; Grant MS; Stepp WH; Clark LH
    Gynecol Oncol Rep; 2019 Nov; 30():100518. PubMed ID: 31867433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma Knife Surgery for Metastatic Brain Tumors from Gynecologic Cancer.
    Matsunaga S; Shuto T; Sato M
    World Neurosurg; 2016 May; 89():455-63. PubMed ID: 26844877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial).
    Nasu K; Satoh T; Nishio S; Nagai Y; Ito K; Otsuki T; Hongo A; Hirashima Y; Ogura T; Shimada M
    Gynecol Oncol; 2013 Feb; 128(2):198-203. PubMed ID: 23142074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical analysis of brain metastasis in gynecologic cancer: a retrospective multi-institute analysis.
    Kim YZ; Kwon JH; Lim S
    J Korean Med Sci; 2015 Jan; 30(1):66-73. PubMed ID: 25552885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear accelerator-based radiosurgery and hypofractionated stereotactic radiotherapy for brain metastasis secondary to gynecologic malignancies: A single institution series examining outcomes of a rare entity.
    Gigliotti MJ; Hasan S; Fuhrer R; Krivak T; Aziz K; Wegner RE
    Gynecol Oncol Rep; 2018 Aug; 25():19-23. PubMed ID: 29977986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes and Prognostic Factors in HER-2 Positive Breast Cancer with Brain Metastasis: A Single-centre Experience.
    Karakaya S; Karadag I; Ates O; Cakmak Oksuzoglu OB; Demirci U
    J Coll Physicians Surg Pak; 2021 Feb; 31(2):166-170. PubMed ID: 33645183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of brain metastasis from esophageal cancer.
    Welch G; Ross HJ; Patel NP; Jaroszewski DE; Fleischer DE; Rule WG; Paripati HR; Ramirez FC; Ashman JB
    Dis Esophagus; 2017 Sep; 30(9):1-6. PubMed ID: 28859365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid Cancer Brain Metastasis: Survival and Genomic Characteristics of a Large Tertiary Care Cohort.
    Osborne JR; Kondraciuk JD; Rice SL; Zhou X; Knezevic A; Spratt DE; Sabra M; Larson SM; Grewal RK
    Clin Nucl Med; 2019 Jul; 44(7):544-549. PubMed ID: 31107749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review.
    Hackshaw MD; Danysh HE; Henderson M; Wang E; Tu N; Islam Z; Ladner A; Ritchey ME; Salas M
    BMC Cancer; 2021 Aug; 21(1):967. PubMed ID: 34454469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes of Gamma Knife Radiosurgery for Metastatic Brain Tumors from Gynecologic Cancer : Prognostic Factors in Local Treatment Failure and Survival.
    Shin HK; Kim JH; Lee do H; Cho YH; Kwon do H; Roh SW
    J Korean Neurosurg Soc; 2016 Jul; 59(4):392-9. PubMed ID: 27446522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.